AstraZeneca’s CALQUENCE® (acalabrutinib) in combination with bendamustine and rituximab has been approved in the US for the treatment of adult patients with previously untreated mantle cell lymphoma ...
The future trends indicate a shift toward solvent-free adhesives, smart tapes with sensors, and customization for specialized uses. The industry is poised for steady growth with innovations and ...